Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes
Diabetes, Obesity and Metabolism | Mar 20, 2019
A comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin-naïve patients with type 2 diabetes
Diabetes, Obesity and Metabolism | Mar 20, 2019
A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5)
Diabetes, Obesity and Metabolism | Mar 20, 2019
Achieving LDL cholesterol target levels <1.81 mmol/l may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study
Diabetes, Obesity and Metabolism | Mar 20, 2019
Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7)
Diabetes, Obesity and Metabolism | Mar 20, 2019
Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes
Diabetes, Obesity and Metabolism | Mar 20, 2019
Effect of cilostazol, a phosphodiesterase-3 inhibitor, on coronary artery stenosis and plaque characteristics in patients with type 2 diabetes (ESCAPE Study)
Diabetes, Obesity and Metabolism | Mar 20, 2019
TBCRC 022: A phase II trial of neratinib and capecitabine for patients with human epidermal growth factor receptor 2–positive breast cancer and brain metastases
Journal of Clinical Oncology | Mar 19, 2019